DONG-A ST CO.,LTD Logo

DONG-A ST CO.,LTD

Develops and distributes ethical drugs, medical devices, and diagnostics for global healthcare.

170900 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울 동대문구 용두동 138 ~255 천호대로 64, 서울
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dong-A ST Co., Ltd. is a specialized pharmaceutical and medical device company that spun off from Dong-A Socio Group in 2013. The company focuses on the development, manufacturing, and global distribution of ethical drugs (ETC), medical devices, and diagnostics. Its pharmaceutical portfolio includes domestically developed new drugs such as Stillen and Zydena, biopharmaceuticals, and chemical drugs. Dong-A ST is also a major global manufacturer of the tuberculosis API, Cycloserine. The medical device and diagnostics division provides comprehensive healthcare solutions in areas including ENT (Ear, Nose, Throat) equipment, in-vitro diagnostics, and infection control systems. With a strong emphasis on research and development, the company actively pursues international expansion through global partnerships and exports.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for DONG-A ST CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 00:00
Prospectus
투자설명서
Korean 2.8 MB
2025-09-09 00:00
Share Issue/Capital Change
증권발행실적보고서
Korean 47.8 KB
2025-09-08 00:00
Registration Form
[발행조건확정]증권신고서(채무증권)
Korean 14.6 KB
2025-09-03 00:00
Registration Form
[기재정정]증권신고서(채무증권)
Korean 3.1 MB
2025-09-03 00:00
Prospectus
[발행조건확정]증권신고서(채무증권)
Korean 275.8 KB
2025-08-28 00:00
Registration Form
증권신고서(채무증권)
Korean 2.8 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.3 MB

Automate Your Workflow. Get a real-time feed of all DONG-A ST CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DONG-A ST CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea 102460
Roche Holding AG Logo
A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.
Switzerland RO
ROHTO PHARMACEUTICAL CO.,LTD. Logo
Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.
Japan 4527
RPbio Inc. Logo
A global CDMO specializing in soft capsules, pharmaceuticals, and health functional foods.
South Korea 314140
Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.
Türkiye RTALB
SAMIL PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs for eye & liver diseases, with a broad portfolio & CDMO services.
South Korea 000520
SAMJIN PHARMACEUTICAL CO.,LTD Logo
Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.
South Korea 005500
SAMSUNG BIOLOGICS CO.,LTD. Logo
A CDMO providing end-to-end development and manufacturing services for the biopharma industry.
South Korea 207940
SanBio Company Limited Logo
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
Japan 4592
SANIGEN Co., Ltd. Logo
Provides food safety solutions and genetic diagnostics for the entire food industry.
South Korea 188260

Talk to a Data Expert

Have a question? We'll get back to you promptly.